Arch Venture Management, LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $189 Million distributed in 11 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Beam Therapeutics Inc. with a value of $77.2M, Vir Biotechnology, Inc. with a value of $65.1M, Verve Therapeutics, Inc. with a value of $22.6M, Erasca, Inc. with a value of $14M, and Gossamer Bio, Inc. with a value of $9.91M.

Examining the 13F form we can see an increase of $67M in the current position value, from $122M to 189M.

Arch Venture Management, LLC is based out at Chicago, IL

Below you can find more details about Arch Venture Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $189 Million
Healthcare: $189 Million

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 11
  • Current Value $189 Million
  • Prior Value $122 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 3 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Arch Venture Management, LLC Portfolio

Follow Arch Venture Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arch Venture Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arch Venture Management, LLC with notifications on news.